Skip to main content

Kiran Datta

NIH Rank #176
  • Top 1% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 79200864Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2024

Linked Award Amount
$15M
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#176
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Kiran Datta. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Award data coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2024): $15M in linked award amounts across 1 award record · Award-linked rank #176.

FY2024 award records by amount

NIH award records listing Kiran Datta as a PI. Multi-PI records show the full award amount for context.

  • 75N91019D00024-P00001-759102300008-1N01
    Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines
    $15M
    award amount

Award organization

Organizations that administered FY2024 awards listing Kiran Datta as a PI.

FY2024 award administered by Leidos Biomedical Research, Inc. (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Leidos Biomedical Research, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #176
  8. 2024
    Entered Top 25% Nationally
    Ranked #176
  9. 2024
    Entered Top 10% Nationally
    Ranked #176
  10. 2024
    Entered Top 5% Nationally
    Ranked #176
  11. 2024
    Entered Top 1% Nationally
    Ranked #176